AZD5492
TITANium
Phase 1 small_molecule active
Quick answer
AZD5492 for B-Cell Malignancies is a Phase 1 program (small_molecule) at AstraZeneca AB with 1 ClinicalTrials.gov record(s).
Program details
- Company
- AstraZeneca AB
- Indication
- B-Cell Malignancies
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active